Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-25-000679
Filing Date
2025-11-14
Accepted
2025-11-14 13:01:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13956
2 logosex99_1.htm EX-99.1 5123
  Complete submission text file 0000935836-25-000679.txt   20814
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Subject) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86603 | Film No.: 251483799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 LETTERMAN DRIVE BLDG C, SUITE C3-350 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE BLDG C, SUITE C3-350 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

EIN.: 833997742 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A